Ayala Pharmaceuticals Inc (ADXS)
0.6455
+0.04
(+7.40%)
USD |
OTCM |
Apr 17, 16:00
Ayala Pharmaceuticals Accounts Payable (Quarterly): 6.076M for Dec. 31, 2023
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 6.076M |
| September 30, 2023 | 5.056M |
| June 30, 2023 | 4.42M |
| December 31, 2022 | 4.08M |
| September 30, 2022 | 2.326M |
| June 30, 2022 | 3.254M |
| March 31, 2022 | 2.564M |
| December 31, 2021 | 3.214M |
| Date | Value |
|---|---|
| September 30, 2021 | 2.888M |
| June 30, 2021 | 2.833M |
| March 31, 2021 | 3.004M |
| December 31, 2020 | 3.726M |
| September 30, 2020 | 3.646M |
| June 30, 2020 | 3.565M |
| March 31, 2020 | 3.362M |
| December 31, 2019 | 2.922M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
2.326M
Minimum
Sep 2022
6.076M
Maximum
Dec 2023
3.558M
Average
3.308M
Median
Accounts Payable (Quarterly) Benchmarks
| Taro Pharmaceutical Industries Ltd | 51.18M |
| InspireMD Inc | 0.939M |
| BiomX Inc | 1.381M |
| Alpha Tau Medical Ltd | 2.566M |
| Pluri Inc | 1.104M |